The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Flagged first, then by citations
2 of the 145 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 801–900 of 1,000
Li, H., Zhang, X., Shen, S., Zhang, Y., Zhang, W., Feng, W., Li, P., & Zhu, D. (2018) · Steroids · doi:10.1016/j.steroids.2018.04.002 · Cited by 12
High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism
Gan, W., Lin, W., Ouyang, J., Li, Y., Chen, D., Yao, Z., & Feng, P. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-018-0112-8 · Cited by 12
Li, M., Ge, Q., Sheng, C., Zhang, J., Li, H., Niu, W., Tang, X., Xu, J., Gao, P., Wang, J., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0208-9 · Cited by 12
Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism
Saiki, A., Otsuki, M., Mukai, K., Hayashi, R., Shimomura, I., Kurihara, I., Ichijo, T., Takeda, Y., Katabami, T., Tsuiki, M., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa011 · Cited by 12
Utility of microcatheter in adrenal venous sampling for primary aldosteronism
Noda, Y., Goshima, S., Nagata, S., Kawada, H., Tanahashi, Y., Kato, T., Suwa, T., Kawai, N., Yabe, D., & Matsuo, M. (2020) · British Journal of Radiology · doi:10.1259/bjr.20190636 · Cited by 12
William F. Young (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00016-2 · Cited by 11
Thiesmeyer, J. W., Ullmann, T. M., Greenberg, J. A., Williams, N., Limberg, J. N., Stefanova, D. I., Beninato, T. M., Finnerty, B. M., Vignaud, T., Leclerc, J., et al. (2020) · Surgery · doi:10.1016/j.surg.2020.04.017 · Cited by 12
ATP1A1 Mutant in Aldosterone-Producing Adenoma Leads to Cell Proliferation
Kobuke, K., Oki, K., Gómez-Sánchez, C. E., Gómez-Sánchez, E. P., Itcho, K., Ohno, H., Nagano, G., Yoshii, Y., Baba, R., Kodama, T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010981 · Cited by 13
Tandem Mass Spectrometry in Hormone Measurement
Field, H. P. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-616-0_4 · Cited by 14
A Case of Adrenocortical Oncocytoma Occurring with Aldosteronoma
Terui, K., Sakihara, S., Kageyama, K., Nigawara, T., Takayasu, S., Matsuhashi, Y., Kon, A., Yamamoto, H., Οhyama, C., Sasano, H., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2787 · Cited by 11
Aldosterone testing: evaluation of a novel automated immunoassay
Derlet, F., Lepoutre, T., & Gruson, D. (2013) · Biomarkers · doi:10.3109/1354750x.2013.865276 · Cited by 12
Elliott, W. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.02.028 · Cited by 12
Li, X., Wang, B., Tang, L., Zhang, Y., Chen, L., Gu, L., Zhang, F., Ouyang, J., & Zhang, X. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00950 · Cited by 12
Sun, L., Jiang, Y., Xie, J., Zhu, H., Wu, L., Zhong, X., Zhou, W., Su, T., & Wang, W. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.751770 · Cited by 11
Yazdanpanah, M., Delaney, S. R., & Beriault, D. R. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad065 · Cited by 11
Primary aldosteronism: A contrarian view
Kaplan, N. M. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9160-x · Cited by 11
Grübler, M. R., Kienreich, K., Gaksch, M., Verheyen, N., Fahrleitner‐Pammer, A., Schmid, J., Grogorenz, J., Ablasser, K., Pieske, B. M., Tomaschitz, A., et al. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12274 · Cited by 11
Secondary Hypertension Due To Concomitant Aldosterone-Producing Adenoma and Parathyroid Adenoma
Chau, K., Holmes, D. T., Melck, A. L., & Chan-Yan, C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu102 · Cited by 11
Clinical Diagnosis and Management of Resistant Hypertension
Tsioufis, C. P., Kasiakogias, A., & Tousoulis, D. M. (2016) · European Cardiology Review · doi:10.15420/ecr.2016:1:2 · Cited by 11
Molecular genetics of Conn adenomas in the era of exome analysis
Zein, R. M. E., Boulkroun, S., Fernandes-Rosa, F. L., & Zennaro, M. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.006 · Cited by 11
Kocjan, T., Vidmar, G., Vrckovnik, R., & Stankovič, M. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0030 · Cited by 11
Who needs to be screened for primary aldosteronism?
Huang, W., Liu, F.-H., Cheng, H., Tsai, Y., Huang, Y., Lai, T., Lin, Y., Wu, V., Kao, H., Hou, C. J., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.08.021 · Cited by 11
Asmar, M. M., Wachtel, H., Yan, Y., Fraker, D. L., Cohen, D. L., & Trerotola, S. O. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23963 · Cited by 11
Larouche, V., Snell, L. S., & Morris, D. V. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0087 · Cited by 11
Grillo, A., Bernardi, S., Rebellato, A., Fabris, B., Bardelli, M., Burrello, J., Rabbia, F., Veglio, F., Fallo, F., & Carretta, R. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12551 · Cited by 11
Primary aldosteronism: comparison between guidelines of the Japanese and the US Endocrine Society
Nishikawa, T., Omura, M., Saito, J., & Matsuzawa, Y. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.65 · Cited by 11
A case of adrenal Cushing’s syndrome with bilateral adrenal masses
Guo, Y.-W., Hwu, C., Won, J. G. S., Chu, C., & Lin, L. (2016) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0118 · Cited by 11
Role of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing Adenomas and Adrenocortical Cells
Tetti, M., Castellano, I., Veneziano, F., Magnino, C., Veglio, F., Mulatero, P., & Monticone, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061675 · Cited by 11
Liu, K., Wang, B., Ma, X., Li, H., Zhang, Y., Li, J., Yao, Y., Tang, L., Xuan, Y., Guo, A., et al. (2019) · Medical Science Monitor · doi:10.12659/msm.913826 · Cited by 11
Ishidoya, S., Kawasaki, Y., Namiki, S., Morimoto, R., Takase, K., & Ito, A. (2019) · International Journal of Urology · doi:10.1111/iju.14016 · Cited by 11
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
Zhu, K., Zhang, Y., Zhang, W., Li, H., Feng, W., Zhu, D., & Li, P. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0390-3 · Cited by 11
Meng, X., Ma, W., Jiang, X., Lu, P., Zhang, Y., Fan, P. T., Cai, J., Zhang, H., Song, L., Wu, H., et al. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0241-8 · Cited by 11
Becker, L. S., Hinrichs, M. H., Werncke, T., Dewald, C. L. A., Maschke, S. K., Limbourg, F. P., Ringe, K. I., Hinrichs, J. B., Wacker, F. K., & Meyer, B. C. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03003-0 · Cited by 11
Liu, Z., He, M., Song, X., Xu, F., Zhang, B., Chen, B., Yu, P., Zhou, H., Shan, L., Wang, H., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002852 · Cited by 11
Primary Aldosteronism: a Continuum from Normotension to Hypertension
Wannachalee, T., & Turcu, A. F. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01538-8 · Cited by 11
Ozeki, Y., Kinoshita, M., Miyamoto, S., Yoshida, Y., Okamoto, M., Gotoh, K., Masaki, T., Kambara, K., & Shibata, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.859347 · Cited by 11
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism
Williams, T. A., Mulatero, P., Bidlingmaier, M., Beuschlein, F., & Reincke, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05643 · Cited by 11
Chen, Y., Su, Y., Wei, C., Chiu, J.-S., Tseng, C.-E., Chen, S.-J., & Wang, Y. (2011) · BioMed Research International · doi:10.1155/2011/209787 · Cited by 11
Adrenal incidentaloma: A puzzle for clinician
Jain, S. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.119507 · Cited by 11
Aldosterone determination: Comparison of a RIA assay and a CLIA assay
Belaïdi, N., Georges, A., Brossaud, J., & Corcuff, J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.10.008 · Cited by 11
Olala, L. O., Shapiro, B. A., Merchen, T. C., Wynn, J. D., & Bollag, W. B. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.015 · Cited by 11
Primary and Secondary Hypertension
Blumenfeld, J. D., Liu, F., & Laragh, J. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10046-6 · Cited by 11
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio
Lőcsei, Z., Horvath, D. E., Rácz, K., Szabolcs, I., Kovács, G. L., & Toldy, E. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.06.025 · Cited by 11
Inherited Disorders of Renal Salt Homeostasis
Scholl, U. I., & Lifton, R. P. (2013) · Seldin and Giebisch's The Kidney · doi:10.1016/b978-0-12-381462-3.00036-7 · Cited by 10
Wang, X., Heinrich, D. A., Kunz, S. L., Heger, N., Sturm, L., Uhl, O., Beuschlein, F., Reincke, M., & Bidlingmaier, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-90901-4 · Cited by 10
Lu, Y., Liu, K., Wu, V., Wang, S., Lin, Y., Chueh, S., Wu, K., Huang, K., & the Taiwan Primary Aldosteronism Investigation Study Group (2022) · International Journal of Urology · doi:10.1111/iju.14905 · Cited by 10
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas
Pitsava, G., Faucz, F. R., Stratakis, C. A., & Hannah‐Shmouni, F. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01735-z · Cited by 10
Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy
Pofi, R., Bonaventura, I., Duffy, J., Maunsell, Z., Shine, B. S. F., Isidori, A. M., & Tomlinson, J. (2023) · Endocrine Connections · doi:10.1530/ec-23-0059 · Cited by 12
Vignaud, T., Baud, G., Nominé-Criqui, C., Donatini, G., Santucci, N., Hamy, A., Lifante, J., Maillard, L., Mathonnet, M., Chéreau, N., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006026 · Cited by 10
Sechi, L. A., & Catena, C. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.08.004 · Cited by 10
A Case of Myelolipoma with Bilateral Adrenal Hyperaldosteronism Cured after Unilateral Adrenalectomy
Inuzuka, M., Tamura, N., Sone, M., Taura, D., Sonoyama, T., Honda, K., Kojima, K., Fukuda, Y., Ueda, Y., Yamashita, Y., et al. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.5777 · Cited by 10
Update on diagnosis and treatment of resistant hypertension.
Pimenta, E. (2011) · Iranian Journal of Kidney Diseases · Cited by 10
Genetics of Primary Aldosteronism
Vaidya, A., Hamrahian, A. H., & Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14512.ra · Cited by 10
Die Klug-entscheiden-Initiative der Deutschen Gesellschaft für Innere Medizin
Feldkamp, J., Schott, M., Gogol, M., Quinkler, M. O., Blüher, M., Diederich, S., & Reincke, M. (2016) · Der Internist · doi:10.1007/s00108-016-0072-4 · Cited by 10
The Clinical Value of Salivary Aldosterone in Diagnosis and Follow-Up of Primary Aldosteronism
Lichtenauer, U. D., Gerum, S., Asbach, E., Manolopoulou, J., Fourkiotis, V., Quinkler, M. O., Bidlingmaier, M., & Reincke, M. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-114037 · Cited by 10
Image Fusion Guidance with Pre-procedural CT with Real-Time Fluoroscopy for Adrenal Venous Sampling
Morita, S., Yamazaki, H., Endo, K., Suzaki, S., Mitsuhashi, A., Shiohara, T., Yatabe, M., Ichihara, A., & Sakai, S. (2018) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-018-1930-3 · Cited by 10
Zavatta, G., Dalmazi, G. D., Pizzi, C., Bracchetti, G., Mosconi, C., Balacchi, C., Pagotto, U., & Vicennati, V. (2018) · Endocrine · doi:10.1007/s12020-018-1801-3 · Cited by 10
A disease-specific Quality of Life questionnaire for primary aldosteronism
Velema, M. S., de Nooijer, A., Hermus, A. R., Timmers, H. J. L. M., Lenders, J. W. M., Husson, O., & Deinum, J. (2019) · Endocrine Connections · doi:10.1530/ec-19-0026 · Cited by 10
Wang, M., Li, N., Luo, Q., Wang, G., Heizhati, M., Wang, L., Wang, L., & Zhang, W. (2021) · Endocrine · doi:10.1007/s12020-021-02745-7 · Cited by 10
Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I
Safaryan, A. S., & Sargsyan, V. D. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-2693 · Cited by 12
Liu, Z., Deng, X., Luo, L., Li, S., Li, M., Deng, Q., Zhong, W., & Luo, Q. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001906 · Cited by 10
Strategies for subtyping primary aldosteronism
Yang, Y.-H., Chang, Y., Lee, B., Lu, C., Wang, W., Hu, Y., Liu, H.-W., Lin, Y., Chang, C., Wu, W.-C., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.05.004 · Cited by 10
Outcome of Surgery for Primary Hyperaldosteronism
Liao, C., Wu, V., Chueh, S., & Sankari, B. R. (2012) · World Journal of Surgery · doi:10.1007/s00268-011-1370-6 · Cited by 10
Left ventricle remodeling in men with moderate to severe volume-dependent hypertension
Indra, T., Holaj, R., Zelinka, T., Petrák, O., Štrauch, B., Rosa, J., Krátká, Z., Malík, J., Janota, T., Hradec, J., et al. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312446240 · Cited by 10
Morita, S., Endo, K., Suzaki, S., Ishizaki, U., Yamazaki, H., Nishina, Y., & Sakai, S. (2017) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-017-1567-7 · Cited by 10
Glucocorticoid-remediable aldosteronism.
Dluhy, R. G., & Williams, G. H. (1996) · PubMed · Cited by 10
Primary Aldosteronism: New Answers, New Questions
Funder, J. W. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565182 · Cited by 9
Self-citationHow can resistant hypertension be identified and prevented?
Solini, A., & Ruilope, L. M. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.23 · Cited by 9
Hypertension artérielle d’origine surrénale : reconnaître, évaluer et prendre en charge
Amar, L., Lorthioir, A., Giavarini, A., Plouin, P., & Azizi, M. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.032 · Cited by 9
Treatment of primary hyperaldosteronism
Castro, M. A. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.04.022 · Cited by 9
O’Toole, S. M., Hornby, C., Sze, W.-C., Hannon, M. J., Akker, S. A., Druce, M. R., Waterhouse, M., Dawnay, A., Sahdev, A., Matson, M. B., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14534 · Cited by 9
Castro, M. A., Corrales, E. P., Rojas, P. M., & Ramírez, P. A. P. (2023) · Endocrine · doi:10.1007/s12020-023-03573-7 · Cited by 9
Satoh, F., Morimoto, R., Iwakura, Y., Ono, Y., Kudo, M., Takase, K., & Ito, S. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9161-9 · Cited by 9
Hypertension artérielle endocrine
Amar, L., Lussey‐Lepoutre, C., Bobrie, G., & Plouin, P. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.08.015 · Cited by 9
Primary aldosteronism and its various clinical scenarios
Martell‐Claros, N., Abad-Cardiel, M., Álvarez-Álvarez, B., García‐Donaire, J. A., & Fernández, C. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000546 · Cited by 9
Terui, K., Kageyama, K., Nigawara, T., Moriyama, T., Sakihara, S., Takayasu, S., Tsushima, Y., Watanki, Y., Yamagata, S., Sugiyama, A., et al. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315625703 · Cited by 9
Vakkalanka, S., Zhao, A., & Samannodi, M. S. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-216209 · Cited by 9
Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
Romero, D. G. (2016) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.129 · Cited by 9
Capítulo 12 - Hipertensão Arterial Secundária
Malachias, M. V. B., Souza, W., Plavnik, F. L., Rodrigues, C., Brandão, A., Neves, M. F., Bortolotto, L. A., Franco, R., Figueiredo, C., Jardim, P., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160162 · Cited by 10
Ahn, H., Chun, E. J., Lee, H. J., Hwang, S. I., Choi, D., Chae, I., & Lee, K. W. (2018) · Korean Journal of Radiology · doi:10.3348/kjr.2018.19.2.272 · Cited by 10
Lie, M., & Thorstensen, K. (2018) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1480060 · Cited by 9
Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis
Chang, C., Chen, Y., Lai, T., Zeng, Y.-H., Chen, C.-K., Tu, K., Lu, C., Wu, V., & Er, L. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.08.001 · Cited by 9
Chapter 13. Secondary hypertension
(2014) · Hypertension Research · doi:10.1038/hr.2014.16 · Cited by 10
Validation of three novel clinical prediction tools for primary aldosteronism subtyping
Kocjan, T., Vidmar, G., Popovič, P., & Stankovič, M. (2022) · Endocrine Connections · doi:10.1530/ec-21-0532 · Cited by 9
Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link?
Williams, T. A., Dietz, A., Theodoropoulou, M., Riester, A., Fischer, E., Burrello, J., Treitl, M., Geyer, L. L., Veglio, F., Bidlingmaier, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2422 · Cited by 9
Diagnosis and differential diagnosis of adrenal incidentalomas
Молашенко, Н. В., Platonova, N. M., Beltsevich, D. G., Yukina, M. Y., & Troshina, E. A. (2016) · Obesity and metabolism · doi:10.14341/omet2016439-44 · Cited by 9
Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas
Gómez-Sánchez, C. E., Kuppusamy, M., & Gómez-Sánchez, E. P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.004 · Cited by 9
Primary aldosteronism and a Texas two-step
Auchus, R. J. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9157-5 · Cited by 9
Primary hyperaldosteronism: challenges in subtype classification
Layden, B. T., Hahr, A. J., & Elaraj, D. M. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-602 · Cited by 9
Toušek, P., Widimsky, J., Jr., Rosa, J., Čurila, K., Branny, M., Nykl, I., Táborský, M., Václavík, J., & Widimský, P. (2014) · Cor et Vasa · doi:10.1016/j.crvasa.2014.04.004 · Cited by 9
Hayakawa, E., Yoshimoto, T., Hiraishi, K., Kato, M., Izumiyama, H., Sasano, H., & Hirata, Y. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4351 · Cited by 9
Spyridonidis, T., & Apostolopoulos, D. J. (2013) · PubMed · Cited by 9
Kuo, C., Balakrishnan, P., Hsein, Y.-C., Wu, V., Chueh, S., Chen, Y.-M., Wu, K., Wang, M., TAIPAI group, Wu, V., et al. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313498632 · Cited by 9
NP-59 test for preoperative localization of primary hyperaldosteronism
Martino, M. D., Sanz, Í. G., de Nova, J. L. M., Campos, C. M., Martín, M. M., & Gadea, L. D. (2017) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-017-1561-1 · Cited by 9
Mourtzinis, G., Ebrahimi, A., Gustafsson, H., Johannsson, G., & Manhem, K. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-119220 · Cited by 9
Noro, E., Yokoyama, A., Kobayashi, M., Shimada, H., Suzuki, S., Hosokawa, M., Takehara, T., Parvin, R., Shima, H., Igarashi, K., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051406 · Cited by 9
The influence of the peripheral cortisol fluctuation on the success rate of adrenal venous sampling
Chang, C., Lee, B., Liu, K., Chang, Y., Wu, V., Huang, K., & Wu, T.-H. (2018) · Scientific Reports · doi:10.1038/s41598-018-20647-z · Cited by 9
Zhang, Z., Sugiura, Y., Mune, T., Nishiyama, M., Terada, Y., Mukai, K., & Nishimoto, K. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000487 · Cited by 9
Vorselaars, W. M. C. M., van Beek, D., Suurd, D. P. D., Postma, E. L., Spiering, W., Rinkes, I. H. M. B., Valk, G. D., Vriens, M. R., CONNsortium*, I., Zarnegar, R., et al. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05408-2 · Cited by 9
Preclinical cardiac disease in women and men with primary aldosteronism
Aune, A., Kokorina, M., Grytaas, M. A., Midtbø, H. B., Løvås, K., & Gerdts, E. (2021) · Blood Pressure · doi:10.1080/08037051.2021.1904775 · Cited by 9
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
